Karen Reeves
Corporate Officer/Principal presso LIGAND PHARMACEUTICALS INCORPORATED
Posizioni attive di Karen Reeves
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 20/02/2024 | - |
AZTherapies, Inc.
 AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA. | Direttore Tecnico/Scientifico/R&S | 01/09/2017 | - |
| Presidente | 01/09/2017 | - |
Storia della carriera di Karen Reeves
Precedenti posizioni note di Karen Reeves
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| KIROMIC BIOPHARMA, INC. | Direttore/Membro del Consiglio | 14/02/2022 | 06/12/2022 |
| Independent Dir/Board Member | 14/02/2022 | 06/12/2022 | |
| MEDIVATION INC | Corporate Officer/Principal | 18/12/2009 | 29/03/2010 |
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | - | - |
| PFIZER, INC. | Corporate Officer/Principal | - | - |
Formazione di Karen Reeves
| Yale University | Undergraduate Degree |
| University of Vermont College of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
| Giappone | 2 |
Posizioni
| Corporate Officer/Principal | 4 |
| Undergraduate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Settori
| Health Technology | 7 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| KIROMIC BIOPHARMA, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| ASTELLAS PHARMA INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
AZTherapies, Inc.
AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Karen Reeves
- Esperienza
